- Home
- RIOT vs PTGX Comparison
RIOT vs PTGX Comparison
Compare RIOT & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RIOT | PTGX |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.4B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | RIOT | PTGX |
|---|---|---|
| Price | $15.27 | $82.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 9 |
| Target Price | $26.13 | ★ $93.00 |
| AVG Volume (30 Days) | ★ 14.0M | 909.6K |
| Earning Date | 02-23-2026 | 02-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 693.97 | N/A |
| EPS | 0.40 | ★ 0.72 |
| Revenue | ★ $637,162,000.00 | $209,217,000.00 |
| Revenue This Year | $78.69 | N/A |
| Revenue Next Year | $11.24 | $288.98 |
| P/E Ratio | ★ $37.24 | $114.23 |
| Revenue Growth | ★ 103.62 | N/A |
| 52 Week Low | $6.19 | $33.70 |
| 52 Week High | $23.94 | $96.54 |
Technical Indicators
Market Signals| Indicator | RIOT | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 55.37 | 35.78 |
| Support Level | $12.62 | $84.11 |
| Resistance Level | $13.95 | $89.61 |
| Average True Range (ATR) | 0.76 | 3.13 |
| MACD | 0.27 | -1.11 |
| Stochastic Oscillator | 96.15 | 19.24 |
Price Performance
Historical ComparisonAbout RIOT Riot Platforms Inc.
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.